Lantheus Holdings to Showcase Innovations at Conferences

Author: Evelyn Baker Updated: 02-21-2025 08:32 AM

Upcoming Investor Conferences Featuring Lantheus Holdings

Bedford, Massachusetts — Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH) is rapidly becoming a key player in the radiopharmaceutical sector. The company is dedicated to empowering healthcare professionals to Find, Fight, and Follow diseases, ultimately aiming for improved patient outcomes. In exciting news, Lantheus has announced the participation of its management team in several upcoming investor conferences, making it an important event for potential investors and stakeholders.

Details of the Conferences

The conferences include the B. Riley Securities Precision Oncology & Radiopharma Day, which will be held in the vibrant city of New York. This event is set for February 28 and promises significant insights into precision oncology and the role of radiopharmaceuticals.

Next on the agenda is the TD Cowen 45th Annual Health Care Conference taking place in Boston on March 4 at 2:30 pm ET. This prestigious annual gathering is known for bringing together leaders in the healthcare industry to discuss trends, innovations, and opportunities that affect all aspects of health care.

Lastly, Lantheus will participate in the Leerink Global Healthcare Conference 2025 scheduled for March 11 at 1:40 pm ET in the dynamic city of Miami. This conference will highlight key developments in global healthcare practices and innovations.

How to Access the Presentations

For those unable to attend in person, a live webcast will be accessible through the Investors section of Lantheus' official website at www.lantheus.com. Following the live presentations, replays of the discussions will also be made available online for at least 30 days, ensuring that interested individuals can stay informed about the company's insights and advancements.

About Lantheus Holdings

Lantheus is at the forefront of the radiopharmaceutical landscape, with a proud history spanning over 65 years. The company specializes in delivering innovative radiopharmaceutical solutions designed to assist healthcare professionals in diagnosing and treating diseases effectively. Headquartered in Massachusetts, with additional offices located in Canada and Sweden, Lantheus is committed to reshaping healthcare practices and enhancing patient outcomes through pioneering science.

Leadership Commitment

The leadership team at Lantheus plays an essential role in navigating the company through the evolving healthcare landscape. Their participation in key conferences is a testament to their dedication to transparency, innovation, and stakeholder engagement.

Company Contacts

For any inquiries regarding the company's performance or future strategies, interested parties can reach out to:

Mark Kinarney
Vice President, Investor Relations
978-671-8842
ir@lantheus.com
Melissa Downs
Senior Director, External Communications
646-975-2533
media@lantheus.com

Frequently Asked Questions

What is Lantheus Holdings?

Lantheus Holdings is a leading company in the radiopharmaceutical sector, focused on disease detection and management.

What upcoming conferences will Lantheus participate in?

Lantheus will present at the B. Riley Securities Precision Oncology & Radiopharma Day, TD Cowen Annual Health Care Conference, and the Leerink Global Healthcare Conference.

Where can I watch the presentations?

The presentations will be available via live webcast on Lantheus' official website and can be accessed for 30 days post-event.

How long has Lantheus been in the industry?

Lantheus has been providing innovative radiopharmaceutical solutions for more than 65 years.

How can I contact Lantheus for more information?

Contact information for Lantheus' Investor Relations and External Communications team is available on their website.

About The Author

Greetings, I'm 32-year-old author and financial specialist Evelyn Baker. My introduction into the financial industry started with an economics degree and continued with a wealth of experience in wealth management and financial consulting. My great passion over the years has been assisting people and companies in making wise, well-informed decisions to reach their financial objectives.

My goal with writing is to simplify difficult financial ideas into understandable, doable guidance. My goal in writing many books and articles is to make personal finance understandable to everyone, irrespective of their experience or background. I want to give readers the information they need to take charge of their financial futures, from investing and retirement planning to budgeting and saving.

Along with my writing, I lead webinars and workshops where I provide doable advice and methods for achieving financial success. To reach a larger audience, I also frequently contribute to financial blogs and publications. My method is always to offer doable, real-world guidance that can actually improve people's lives.

Aside from my job, I like to cook, travel, and experience other cultures. I work hard to apply my belief in the value of a balanced life to my financial counsel. My goal in working is to encourage and enable people to succeed financially so they may lead the best lives possible.

Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.